ORLANDO, Fla. — A new analysis of three decades of clinical trial data confirms that Black patients with acute myeloid leukemia (AML) have worse survival outcomes than White patients. However, ...
AUSTIN (KXAN) — Hundreds of children and youth were identified as survivors of human trafficking in the past year, a new report from the Texas Department of Family and Protective Services, or DFPS, ...
Simon Potter received funding from the Leverhulme Trust, 2016-2019, for a research project on the history of international broadcasting. The leaked memo raising concerns about BBC impartiality was an ...
Y.S. Chi, chairman of Elsevier and director of RELX, doesn’t mince words when it comes to discussing the future of publishing. "No publisher will survive five years from today if they don't have data, ...
Akeso has data showing ivonescimab can extend the lives of patients with previously treated EGFR-mutated non-small cell lung cancer (NSCLC), results that can give the red-hot PD-(L)1xVEGF bispecific ...
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, announced the first reported median overall survival ...
Abstract: Outsourcing logistic regression classification services to the cloud is highly beneficial for streaming data. However, it raises critical privacy concerns for the input data and the training ...
Truth matters. Community matters. Your support makes both possible. LAist is one of the few places where news remains independent and free from political and corporate influence. Stand up for truth ...
Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. How does a venerable American brand known for creating the ...
Abstract: In the context of evaluating machine learning algorithms for binary classification tasks, predicting passenger survival on the Titanic provides a practical benchmark. The research aims to ...
More than two years after the FDA held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a draft guidance on the topic, recommending that OS be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback